AR046229A1 - Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura - Google Patents

Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura

Info

Publication number
AR046229A1
AR046229A1 ARP040104059A ARP040104059A AR046229A1 AR 046229 A1 AR046229 A1 AR 046229A1 AR P040104059 A ARP040104059 A AR P040104059A AR P040104059 A ARP040104059 A AR P040104059A AR 046229 A1 AR046229 A1 AR 046229A1
Authority
AR
Argentina
Prior art keywords
pivoxil
cefditoren
highly pure
amorphous
pivoxil cefditoren
Prior art date
Application number
ARP040104059A
Other languages
English (en)
Spanish (es)
Inventor
Yatendra Kumar
Mohan Prasad
Kaptan Singh
Ashok Prasad
Santosh Richhariya
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of AR046229A1 publication Critical patent/AR046229A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
ARP040104059A 2003-11-07 2004-11-05 Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura AR046229A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1368DE2003 2003-11-07

Publications (1)

Publication Number Publication Date
AR046229A1 true AR046229A1 (es) 2005-11-30

Family

ID=34566866

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104059A AR046229A1 (es) 2003-11-07 2004-11-05 Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura

Country Status (5)

Country Link
EP (1) EP1689755A2 (zh)
JP (1) JP2007510709A (zh)
CN (1) CN1902207A (zh)
AR (1) AR046229A1 (zh)
WO (1) WO2005044824A2 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003141A2 (en) 2003-07-04 2005-01-13 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of cefditoren
WO2006024900A1 (en) * 2004-08-31 2006-03-09 Ranbaxy Laboratories Limited Highly pure cefditoren pivoxil
US20090111997A1 (en) * 2005-11-23 2009-04-30 Aaron Cote Method of Generating Amorphous Solid for Water-Insoluble Pharmaceuticals
CN101560216B (zh) * 2009-05-27 2011-06-15 上海交通大学 头孢妥仑酯的制备方法
KR101561963B1 (ko) * 2013-05-23 2015-10-22 영진약품공업 주식회사 세프디토렌 피복실의 신규 결정 형태 및 이의 제조 방법
CN106117244B (zh) * 2016-06-24 2018-10-19 瑞阳制药有限公司 头孢妥仑匹酯的精制方法
CN106243128B (zh) * 2016-07-30 2018-09-04 济南康和医药科技有限公司 一种头孢妥仑匹酯的精制方法
CN107422056B (zh) * 2017-08-17 2020-04-24 山东裕欣药业有限公司 一种特戊酸碘甲酯的气相色谱检测方法及其制备方法
CN109053768A (zh) * 2018-08-07 2018-12-21 中国医药集团总公司四川抗菌素工业研究所 一种无定型头孢妥仑酯的制备方法
CN109336904B (zh) * 2018-11-21 2020-06-09 山东罗欣药业集团股份有限公司 一种头孢妥仑匹酯的制备方法
CN110251467A (zh) * 2019-06-26 2019-09-20 北京济美堂医药研究有限公司 一种无定形态头孢妥仑匹酯组合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1116299C (zh) * 1996-09-20 2003-07-30 明治制果株式会社 头孢地托伦新戊酰氧甲酯晶体及其生产方法
KR100435315B1 (ko) * 1998-01-07 2004-06-10 메이지 세이카 가부시키가이샤 결정학적으로 안정된 비정질 세파로스포린 조성물과 그제조 방법
JP2001131071A (ja) * 1999-10-29 2001-05-15 Meiji Seika Kaisha Ltd 非晶質および非晶質を含有する医薬組成物

Also Published As

Publication number Publication date
JP2007510709A (ja) 2007-04-26
EP1689755A2 (en) 2006-08-16
WO2005044824A2 (en) 2005-05-19
CN1902207A (zh) 2007-01-24
WO2005044824A3 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
AR046229A1 (es) Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura
HN2001000110A (es) 5-cloro -3-(metansulfonilfelino)-6-metil-[2.3] bipiridinilo en forma cristalina pura y proceso para la sintesis
RS20150292A1 (en) POLYMORPHIC FORMS OF RIFAXIMINE, PROCEDURES FOR THEIR PRODUCTION AND ITS USE IN MEDICAL PREPARATIONS
ES2170732B2 (es) Procedimiento para preparar citalopram purificado
ES2181663T3 (es) Procedimiento para la preparacion de citalopram puro.
BR0113234A (pt) Polimorfos de um análogo de epotilona
UA109774C2 (uk) Кристалічні форми саксагліптину та процес його одержання (варіанти)
EA201101695A1 (ru) Усовершенствованный способ синтеза пирфенидона
AR048937A1 (es) Proceso para preparar bisulfato de atazanavir forma e3 y material de configuracion c
BR0314133A (pt) Métodos para a preparação, isolamento e purificação de epotilona b e raios x de estruturas de cristal de epotilona b
AR048973A1 (es) (4-metoxi-7-morfolin-4-il-benzotiazol-2-il)amida del acido 4-hidroxi-4-metil-piperidin-1-carboxilico. proceso de preparacion y composiciones farmaceuticas
AR033335A1 (es) Compuestos de acidos 3-propil gama aminobutirico mono y di sustituidos, composicion farmaceutica que los comprende y su uso para fabricar dicha composicion
BR0312152A (pt) método de produção de lipossomos contendo um composto biologicamente ativo, e composição de lipossomos
AR080275A1 (es) Formas solidas de un derivado de n-( fenilmetil) propanamida y procedimientos de preparacion
PE20030944A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
WO2020016847A3 (en) Purification process for preparation of eribulin and intermediates thereof
AR003973A1 (es) Forma cristalina biodisponible de axetil cefuroxima y proceso para producirla
AR113852A1 (es) Procedimiento para la preparación de (3s)-3-(4-cloro-3-{[(2s,3r)-2-(4-clorofenil)-4,4,4-trifluor-3-metilbutanoil]amino}fenil)-3-ácido ciclopropilpropanoico y su forma cristalina para uso como principio activo farmacéutico
AR041678A1 (es) Formas cristalinas de clorhidrato de donepezil
EA200701686A1 (ru) Свободное основание лерканидипина
WO2005080329A3 (en) Process for manufacture of racemic carvedilol
TR200103399T2 (tr) 3-heteroarilalkil ikameli GABA analogları.
AR036018A1 (es) Proceso para aislar monohidrato de imipenem cristalino puro
MX2010007923A (es) Forma cristalina de abacavir que esta esencialmente libre de disolvente.
TW201004913A (en) Preparation of paricalcitol

Legal Events

Date Code Title Description
FB Suspension of granting procedure